Pharmacology

24Apr

CRISPR and Gene Therapy: Purity of Peptide Support API

Analysis of the impact of peptide ligand purity on CRISPR off-target activity. Methodology for the synthesis of API support according to 2026 standards

22Apr

API Synthesis Localization: Global Trends and Technologies AVELife

Global trends in API reshoring and clean synthesis technologies. Institute methodology for ensuring regulatory compliance in localization conditions.

09Apr

Superbug resistance and synthesis of new pharmaceutical reagents

Resistance analysis of ESKAPE strains.. Methodology by A. Demchenko for C-level Pharma.

03Apr

Epigenetic code and tetrapeptides in cell regulation

Analysis of the role of tetrapeptides in epigenetic regulation, telomeric biology, and modern translational biomedicine.

02Apr

Tetrapeptide regulation of gene expression and API synthesis

Scientific analysis of the interaction of tetrapeptides with the nucleosome apparatus. Technologies for the synthesis of high-purity API (>99.5%) according to the methodology of A....

14Mar

Gene therapy, telomerase, telomeres and tetrapeptides: is it possible to renew the telomere reserve?

The role of telomeres, telomerase, and gene therapy in controlling cellular aging. A simple explanation of complex biological processes.

12Mar

Gene Therapy Market: Opportunities, Barriers, and the Real Economy of the Industry

How the gene therapy market works, why it is growing, what is holding it back, and why it is one of the most complex segments...

11Mar

Gene therapy: how treatment works at the DNA level

What is gene therapy, how does it work, and why is it one of the major breakthroughs in modern pharmacology?

28Jan

Hybrid Sourcing in Pharmaceuticals: Risk Map 2026

Risk map 2026 for pharmaceutical procurement: hybrid sourcing, new API geography, stress nodes and alternative supply routes.

21Jan

The Low Price Trap: Why Cheap Procurement Will Kill Margins in 2026

Why the "buy cheaper" strategy no longer works in pharmaceuticals. An analysis of hidden costs, risks, and the new logic of margin management in 2026.

19Jan

Obesity as a chronic multifactorial disease

Obesity has long ceased to be just a consequence of an “unhealthy lifestyle.” Today, it is considered a chronic, relapsing disease.

16Jan

API Regulatory Geography: Risks and Control

How API regulatory geography is changing pharmaceutical procurement in 2026: FDA, EMA, GMP risks, new control areas and impact on TCO.

15Jan

AI in Pharma Procurement 2026: From Reactivity to Proactivity

As of early 2026, the concept of “procurement as a service” is finally a thing of the past. Our institute records a fundamental shift: procurement...

05Dec

Pharmacology of herbal medicines as a path from nature to evidence-based practice

In today's world, where environmental and social pressures are increasing, interest in natural healing systems is returning not as an "alternative", but as an equal...

04Dec

Green transformation of pharmacy combined with ecology

The modern pharmaceutical industry is undergoing a profound paradigm shift. The world is moving away from the “efficiency at any cost” model and towards a...

ABOUT THE INSTITUTE

Areas of research

Документи

Виставки та конференції у світі

Патенти

Органічні добрива

Органічні добрива

Наноматеріали

Органічна хімія

Екологія

Pharmacology

CRISPR and Gene Therapy: Purity of Peptide Support API

API Synthesis Localization: Global Trends and Technologies AVELife

Superbug resistance and synthesis of new pharmaceutical reagents

Epigenetic code and tetrapeptides in cell regulation

Tetrapeptide regulation of gene expression and API synthesis

Gene therapy, telomerase, telomeres and tetrapeptides: is it possible to renew the telomere reserve?

Gene Therapy Market: Opportunities, Barriers, and the Real Economy of the Industry

Gene therapy: how treatment works at the DNA level

Hybrid Sourcing in Pharmaceuticals: Risk Map 2026

The Low Price Trap: Why Cheap Procurement Will Kill Margins in 2026

Obesity as a chronic multifactorial disease

API Regulatory Geography: Risks and Control

AI in Pharma Procurement 2026: From Reactivity to Proactivity

Pharmacology of herbal medicines as a path from nature to evidence-based practice

Green transformation of pharmacy combined with ecology

Documents

Patents

Patents of Ukraine

International patents

Popular articles

Pharmacology news in January 2025: main...

Pharmacology News in February 2025

Pharmacological Breakthrough or Marketing Hype? Top...

Pharmacology at the Crossroads: 5 Breakthroughs...

May 2025 in Pharmacology: Key Trends,...

Pharmacology June 2025: An Industry at...

About the institute

Areas of research

Patents